# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B of A Securities analyst Allen Lutz maintains Walgreens Boots Alliance (NASDAQ:WBA) with a Underperform and lowers the pric...
The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.
JP Morgan analyst Lisa Gill maintains Walgreens Boots Alliance (NASDAQ:WBA) with a Overweight and lowers the price target fr...
Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR.